as on March 11, 2026 at 6:59 am IST
Day's Low
Day's High
3.08%
Downside
10.77%
Upside
52 Week's Low
52 Week's High
17.34%
Downside
574.23%
Upside
Check Trinity Biotech Plc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.9M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.77%
PE Ratio (TTM)
0PEG Ratio
1.3
EBITDA
-13.0M
Revenue (TTM)
61.6M
Profit Margin
-51.64%
Return On Equity TTM
-1913.45%
Compare market cap, revenue, PE, and other key metrics of Trinity Biotech Plc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $15.9M | -99.35% | NA | -51.64% | |
| BUY | $105.9B | 82.77% | 36.78 | 14.44% | |
| BUY | $139.5B | 52.42% | 43.5 | 12.92% | |
| BUY | $116.7B | -23.02% | 25.39 | 13.00% | |
| BUY | $190.4B | -2.79% | 29.37 | 14.72% |
The Trinity Biotech Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Trinity Biotech Plc investment value today
Current value as on today
₹23,871
Returns
Returns from Trinity Biotech Plc Stock
Dollar Returns*
₹5,192 (+5.19%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Trinity Biotech Plc. Average target price of $3
Get share price movements and forecasts by analysts on Trinity Biotech Plc.
What analysts predicted
78.33%UPSIDE
Target Price
$3
Current Price
$0.65
Analyzed by
7 Analysts
Target
$3.00
Trinity Biotech Plc target price $3, a slight upside of 78.33% compared to current price of $0.65. According to 7 analysts rating.
Search interest for Trinity Biotech Plc Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 23 December
Tue, 08:29 PM
-Trinity Biotech stock surged after securing a nine-million-unit order for HIV tests and announcing capital restructuring efforts.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -16.95M → -5.11M (in $), with an average increase of 82.4% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 7.57M → 14.24M (in $), with an average increase of 46.8% per quarter
Against Peers
![]()
In the last 1 year, Edwards Lifesciences Corp. has given 23.2% return, outperforming this stock by 104.2%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 13.3% return, outperforming this stock by 110.4%
Price Dip
![]()
In the last 1 year, TRIB stock has moved down by -81.0%
| Organisation | Trinity Biotech Plc |
| Headquarters | IDA Business Park, Bray, Ireland, A98 H5C8 |
| Industry | Health Technology |
| CEO | Mr. John Gillard |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Eibhlin Kelly | Chief Information Officer |
Mr. John Gillard | President, CEO, Company Secretary & Director |
Mr. Ronan O'Caoimh A.C.A. | Founder, Director & Executive Advisor |
Dr. James Walsh Ph.D. | Executive Director of Business Development & Executive Director |
Paul Murphy | Interim Chief Financial Officer |
Ms. Jacqueline O'Neill | Director of Operations |
Dr. Gary Keating Ph.D. | Chief Technology Officer |
Trinity Biotech Plc share price today is $0.65 as on at the close of the market. Trinity Biotech Plc share today touched a day high of $0.72 and a low of $0.63.
Trinity Biotech Plc share touched a 52 week high of $4.38 on and a 52 week low of $0.54 on . Trinity Biotech Plc stock price today i.e. is closed at $0.65,which is 85.17% down from its 52 week high and 20.98% up from its 52 week low.
Trinity Biotech Plc market capitalisation is $0.00T as on .
Indian investors can start investing in Trinity Biotech Plc (TRIB) shares with as little as ₹91.833 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹918.33 in Trinity Biotech Plc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Trinity Biotech Plc share’s latest price of $0.65 as on March 11, 2026 at 1:29 am IST, you will get 15.3846 shares of Trinity Biotech Plc. Learn more about
fractional shares .
Trinity Biotech Plc stock has given -99.35% share price returns and 26.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?